Highlights
- •Patient reported outcomes measurements (PROMs) are an essential component of comprehensive, patient centered care.
- •Practical considerations and challenges to collecting PROMs in routine gynecologic oncology practice are discussed.
- •Pragmatic, disease-specific recommendations for the use of PROMs are provided for women with gynecologic malignancies.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to Gynecologic OncologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Recommended patient-reported core set of symptoms and quality-of-life domains to measure in ovarian cancer treatment trials.J. Natl. Cancer Inst. Jul 2014; 106
- Randomized study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group comparing quality of life in patients with ovarian cancer treated with cisplatin/paclitaxel versus carboplatin/paclitaxel.Journal of clinical oncology. Feb 1 2006; 24: 579-586
- Assessment of factors that contribute to decreased quality of life in Gynecologic Oncology Group ovarian cancer trials.Cancer. Oct 15 2009; 115: 4857-4864
- A comparison of quality-of-life domains and clinical factors in ovarian cancer patients: a Gynecologic Oncology Group study.J. Pain Symptom Manag. 2010 May; 39: 839-846
- Quality-of-life comparisons in a randomized trial of interval secondary cytoreduction in advanced ovarian carcinoma: a Gynecologic Oncology Group study.Journal of clinical oncology. Aug 20 2005; 23: 5605-5612
- Health-related quality of life during and after intraperitoneal versus intravenous chemotherapy for optimally debulked ovarian cancer: a Gynecologic Oncology Group Study.Journal of clinical oncology. Feb 1 2007; 25: 437-443
- Content validity of the NCCN-FACT ovarian symptom index-18 (NFOSI-18).Gynecol. Oncol. Feb 2015; 136: 317-322
- Cancer treatment and survivorship statistics, 2016.CA Cancer J. Clin. Jul 2016; 66: 271-289
- The impact of obesity and age on quality of life in gynecologic surgery.Am. J. Obstet. Gynecol. Oct 2005; 193: 1369-1375
- Improvement in quality of life after robotic surgery results in patient satisfaction.Gynecol. Oncol. Sep 2015; 138: 727-730
- Quality of life in patients affected by endometrial cancer: comparison among laparotomy, laparoscopy and vaginal approach.Pathology oncology research. Jul 2015; 21: 811-816
- Health-related quality of life after robotic-assisted laparoscopic hysterectomy for women with endometrial cancer—a prospective cohort study.Gynecol. Oncol. Jan 2016; 140: 107-113
- Sexual functioning among endometrial cancer patients treated with adjuvant high-dose-rate intra-vaginal radiation therapy.Int. J. Radiat. Oncol. Biol. Phys. Oct 1 2012; 84: e187-e193
- Sexual function after intracavitary vaginal brachytherapy for early-stage endometrial carcinoma.International journal of gynecological cancer. May 2012; 22: 703-708
- Assessing the quality of life in patients with endometrial cancer treated with adjuvant radiotherapy.International journal of gynecological cancer. Oct 2015; 25: 1526-1533
- Sexual function and quality of life among patients with endometrial cancer after surgery.International journal of gynecological cancer. Mar 2017; 27: 608-612
- Predictors of sexual well-being after endometrial cancer: results of a national self-report survey.Supportive care in cancer. Oct 2014; 22: 2715-2723
- Quality of life, body mass index, and physical activity among uterine cancer patients.International journal of gynecological cancer. Jul 2014; 24: 1027-1032
- Association between body mass index and physical function among endometrial cancer survivors.PLoS One. 2016; 11e0160954
- Quality of life after radical trachelectomy for early-stage cervical cancer: a 5-year prospective evaluation.Gynecol. Oncol. Dec 2016; 143: 596-603
- Sexual functioning and vaginal changes after radical vaginal trachelectomy in early stage cervical cancer patients: a longitudinal study.J. Sex. Med. Feb 2014; 11: 595-604
- Long-term fertility, oncological, and quality-of-life outcomes after trachelectomy in early stage cervical cancer.Arch. Gynecol. Obstet. Apr 2019; 299: 1033-1041
- Long-term prospective longitudinal evaluation of emotional distress and quality of life in cervical cancer patients who remained disease-free 2-years from diagnosis.BMC Cancer. Mar 18 2013; 13: 127
- Randomized phase III trial of cisplatin with or without topotecan in carcinoma of the uterine cervix: a Gynecologic Oncology Group Study.Journal of clinical oncology. Jul 20 2005; 23: 4626-4633
- Quality of life (QOL) outcomes from a randomized trial of cisplatin versus cisplatin plus paclitaxel in advanced cervical cancer: a Gynecologic Oncology Group study.Gynecol. Oncol. May 2006; 101: 296-304
- Phase III study of cisplatin with or without paclitaxel in stage IVB, recurrent, or persistent squamous cell carcinoma of the cervix: a gynecologic oncology group study.Journal of clinical oncology. Aug 1 2004; 22: 3113-3119
- Gynecologic oncology group trials of chemotherapy for metastatic and recurrent cervical cancer.Curr. Oncol. Rep. Nov 2005; 7: 419-434
- Vulvar cancer patients' quality of life: a qualitative assessment.International journal of gynecological cancer. Sep–Oct 2004; 14: 875-881
- A prospective study in the evaluation of quality of life after vulvar cancer surgery.International journal of gynecological cancer. Jan 2015; 25: 166-173
- The unspoken disease: symptom experience in women with vulval neoplasia and surgical treatment: a qualitative study.European journal of cancer care. Nov 2011; 20: 747-758
- The missing voice of patients in drug-safety reporting.N. Engl. J. Med. Mar 11 2010; 362: 865-869
- A randomized phase III trial of VH fibrin sealant to reduce lymphedema after inguinal lymph node dissection: a Gynecologic Oncology Group study.Gynecol. Oncol. Jul 2008; 110: 76-82
- Sexual dysfunction following vulvectomy.Gynecol. Oncol. Apr 2000; 77: 73-77
- The impact of written information and counseling (WOMAN-PRO II Program) on symptom outcomes in women with vulvar neoplasia: a multicenter randomized controlled phase II study.Gynecol. Oncol. Jul 2017; 146: 114-122
- The functional assessment of cancer-vulvar: reliability and validity.Gynecol. Oncol. May 2005; 97: 568-575
- Assessing patient-reported quality of life outcomes in vulva cancer patients: a systematic literature review.International journal of gynecological cancer. May 2018; 28: 808-817
- Sexual health of endometrial cancer survivors before and after a physical activity intervention: a retrospective cohort analysis.Gynecol. Oncol. Dec 2016; 143: 589-595
- Vaginal changes and sexuality in women with a history of cervical cancer.N. Engl. J. Med. May 6 1999; 340: 1383-1389
- Sexual dysfunction in female cancer survivors.Am. J. Clin. Oncol. Feb 2014; 37: 101-106
- Association of ss-hCG surveillance with emotional, reproductive, and sexual health in women treated for gestational trophoblastic neoplasia.Journal of women's health (2002). Mar 2018; 27: 387-393
- The health-related quality of life journey of gynecologic oncology surgical patients: implications for the incorporation of patient-reported outcomes into surgical quality metrics.Gynecol. Oncol. May 2016; 141: 329-335
- Sexual health in women treated for cervical cancer: characteristics and correlates.Gynecol. Oncol. Feb 2007; 104: 428-434
- Maintaining sexual health throughout gynecologic cancer survivorship: a comprehensive review and clinical guide.Gynecol. Oncol. Feb 2016; 140: 359-368
- Sexual health communication between cancer survivors and providers: how frequently does it occur and which providers are preferred?.Psycho-oncology. Sep 2015; 24: 1167-1173
- Communication about sexual problems and sexual concerns in ovarian cancer: qualitative study.BMJ (Clinical research ed). Oct 13 2001; 323: 836-837
- Sex, intimacy, and the gynecologic oncologists: survey results of the New England Association of Gynecologic Oncologists (NEAGO).J. Psychosoc. Oncol. 2007; 25: 61-70
- Psychometric validation of the Female Sexual Function Index (FSFI) in cancer survivors.Cancer. Sep 15 2012; 118: 4606-4618
- The Female Sexual Function Index (FSFI): a multidimensional self-report instrument for the assessment of female sexual function.Journal of sex & marital therapy. Apr–Jun 2000; 26: 191-208
- Applying the Female Sexual Functioning Index to sexual minority women.Journal of women's health (2002). Apr 2012; 21: 401-409
- Phase 1-3 of the cross-cultural development of an EORTC questionnaire for the assessment of sexual health in cancer patients: the EORTC SHQ-22.Cancer medicine. Mar 2018; 7: 635-645
- The clinical value of quality of life assessment in oncology practice-a qualitative study of patient and physician views.Psycho-oncology. Jul 2008; 17: 690-698
- Cancer experiences and health-related quality of life among racial and ethnic minority survivors of young adult cancer: a mixed methods study.Supportive care in cancer. 2016 Dec; 24: 4861-4870
Article info
Publication history
Accepted:
March 16,
2020
Received:
January 7,
2020
Identification
Copyright
© 2020 Published by Elsevier Inc.
